Melissa Rayhill, MD, clinical assistant professor of
neurology, found that only a quarter of headache clinical trials published in the field’s primary journals over nine years were registered in an approved clinical trial registry. Of the registered trials, 38 percent published results that didn’t match what authors initially planned to report.